Taking place in Birmingham 29th and 30th January 2024, the Birmingham Orthopaedic Oncology Meeting will explore current concepts in Chondrosarcoma and Infected Oncology Reconstructions and gain a global consensus on diagnosis and treatment.
The 2-day meeting is hosted by the Birmingham Orthopaedic Oncology Service at the Royal Orthopaedic Hospital NHS Foundation Trust, and is headed by Lee Jeys, Vineet Kurisunkal and Guy Morris.
Guy Morris, Consultant Orthopaedic Surgeon at the Royal Orthopaedic Hospital, said: “In a speciality as critical as Orthopaedic oncology, decisions about treating patients can be difficult with little evidence or conflicting evidence about key topics.
“There is currently a wide discrepancy in diagnosis and treatment around the world and with recent changes in definition of chondrosarcoma by the World Health Organisation (WHO), this has led to further confusion about optimal treatment. Added to this is the challenge of diagnosis and treatment due to histological assessment as biopsies are rarely accurate in establishing aggressiveness of tumours, which can result in varied management strategies and poorer oncological outcomes.”
In addition to a discussion on chondrosarcomas, the consensus will consider Infected Oncology Reconstructions. Periprosthetic joint infection (PJI) remains one of the dreaded complications of surgery for bone tumours. While management of this complication is well defined in revision arthroplasty, it is not within oncological surgery given the different treatments patients undergo (chemotherapy, radiotherapy, etc) and especially due to the higher prevalence of primary bone cancer in young patients.
The Birmingham Orthopaedic Oncology Service at the Royal Orthopaedic Hospital is the leading centre for orthopaedic oncology in the world. The team specialises in the diagnosis and treatment of benign and malignant tumours of bone and soft tissues and has published over 90 scientific publications on PJI in arthroplasty and Oncology and over 67 papers on chondrosarcoma.
Professor Lee Jeys, Consultant Orthopaedic Surgeon at the Royal Orthopaedic Hospital, added: “This meeting will welcome over 300 attendees from over 50 countries and bring together orthopaedic oncology specialists from across the globe for the first time to agree international guidelines. We’re looking forward to the outcome of the consensus as it will help co-ordinate orthopaedic oncological practices here in the UK and across the globe.”
